Onward Medical N.V.
ONWRF
$4.60
-$0.39-7.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 482.74% | 490.53% | -77.85% | -77.31% | -135.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 482.74% | 490.53% | -77.85% | -77.31% | -135.22% |
| Cost of Revenue | 5.78% | 7.90% | -23.07% | -21.25% | -8.46% |
| Gross Profit | 21.25% | 19.67% | 16.44% | 14.46% | -14.31% |
| SG&A Expenses | 21.56% | 24.00% | 6.00% | 8.52% | -6.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.16% | 9.31% | -4.89% | -2.63% | -5.24% |
| Operating Income | 4.48% | 2.55% | 1.28% | -1.06% | -3.87% |
| Income Before Tax | -1.12% | -3.15% | 4.55% | 2.28% | -0.92% |
| Income Tax Expenses | 343.71% | 353.41% | -798.37% | -816.18% | 108.16% |
| Earnings from Continuing Operations | -2.38% | -4.44% | 6.40% | 4.18% | -6.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.38% | -4.44% | 6.40% | 4.18% | -6.13% |
| EBIT | 4.48% | 2.55% | 1.28% | -1.06% | -3.87% |
| EBITDA | 4.82% | 3.03% | 1.85% | -0.48% | -3.64% |
| EPS Basic | 43.32% | 42.19% | 18.55% | 16.64% | -5.92% |
| Normalized Basic EPS | 44.05% | 42.93% | 16.94% | 15.00% | -0.75% |
| EPS Diluted | 43.45% | 42.32% | 18.12% | 16.17% | -5.38% |
| Normalized Diluted EPS | 44.05% | 42.93% | 16.94% | 15.00% | -0.75% |
| Average Basic Shares Outstanding | 80.66% | 80.66% | 14.93% | 14.93% | 0.19% |
| Average Diluted Shares Outstanding | 80.66% | 80.66% | 14.93% | 14.93% | 0.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |